Sign In
5 Nov 2018 14:00
5 November 2018
Cello Health plc
("Cello", the "Company", or the "Group")
Directorate Change
Cello Health plc (AIM: CLL), the global healthcare focused advisory group, is pleased to announce the appointment of Chris Jones as Non-Executive Chairman of the Group with immediate effect, following the retirement of Allan Rich from the Board.
Chris Jones has been a Non-Executive Director of Cello since October 2016. He was formerly Global Chairman and CEO of J Walter Thompson Co based in New York, part of WPP Group plc. Amongst other directorships, Chris is also a director of Becton Dickinson & Co, the major US-based multinational medical technology company.
Mark Scott, Chief Executive, commented: "The Board wishes to wholeheartedly thank Allan Rich for his invaluable contribution to Cello over the years from its inception. Chris knows the group and the healthcare industry well and can help guide the Board through the Group's next stage of growth and development."
Enquiries:
Cello Group | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Finance Director | |
Cenkos Securities | 0207 397 8900 |
Mark Connelly Harry Hargreaves |
Appendix
Full name (age) |
Christopher Ian Montague Jones (63) |
Current directorships / partnerships: |
CELLO HEALTH PLC BECTON, DICKINSON AND COMPANY PALMER HARGREAVES HOLDINGS LIMITED THE PEW TRUSTS INTERNATIONAL INSTITUTE FOR STRATEGIC STUDIES 17-18 BUCKINGHAM STREET FREEHOLD LIMITED DRAGON ACADEMY HOLDINGS LIMITED BLACKBIRD ACADEMY TRUST RESULTS INTERNATIONAL GROUP LLP DRAGON SCHOOL TRUST LIMITED ST.EDWARD'S SCHOOL |
Previous directorships / partnerships (in the last five years): |
6AM (UK) LTD COVENANT HEALTHCARE GROUP LIMITED THE PAVILION CLINIC LTD GRAND UNION COMMUNICATIONS LIMITED EKINO LIMITED FULLSIX MEDIA LIMITED AMIGO MANAGEMENT SERVICES LTD AMIGO LOANS LTD RICHMOND GROUP LIMITED MOTION EQUITY PARTNERS LLP |
As at today's date, Mr Jones holds 22,726 ordinary shares in the capital of the Company.
There are no further disclosures to be made pursuant to Schedule 2(g) of the AIM Rules for Companies in respect of Mr Jones' appointment.
Follow the stocks
